SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-22-042381
Filing Date
2022-11-18
Accepted
2022-11-18 20:13:49
Documents
2
Period of Report
2022-11-16

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 4933
2 EXHIBIT 24 brhc10044454_ex24.htm EX-24 5510
  Complete submission text file 0001140361-22-042381.txt   11850
Mailing Address C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address
Dupont Jakob (Reporting) CIK: 0001553335 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36548 | Film No.: 221403278

Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Issuer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)